Phase II trial of irinotecan and cisplatin combination as first-line chemotherapy in patients with advanced esophageal squamous-cell carcinoma: An interim report

被引：1
|
作者：
Zhang, X.
Shen, L.
Li, J.
Li, Y.
Zhou, J.
Lu, Z.
Lu, M.
机构：
[1] Peking Univ, Canc Hosp & Inst, Dept Gastrointestinal Oncol, Beijing 100871, Peoples R China
[2] Peking Univ, Canc Hosp, Dept Gastrointestinal Oncol, Beijing 100871, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 04期
关键词：
D O I：
10.1200/jco.2011.29.4_suppl.137
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
137
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A phase II study of capecitabine and cisplatin (XP) as first-line chemotherapy in patients with advanced esophageal squamous cell carcinoma
    Lee, Jeeyun
    Im, Young-Hyuck
    Cho, Eun Yoon
    Hong, Yong Sang
    Lee, Hyo Rak
    Kim, Hyo Song
    Kim, Mi-Jin
    Kim, Kwhanmien
    Kang, Won Ki
    Park, Keunchil
    Shim, Young Mog
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 62 (01) : 77 - 84
  • [2] A phase II study of capecitabine and cisplatin (XP) as first-line chemotherapy in patients with advanced esophageal squamous cell carcinoma
    Jeeyun Lee
    Young-Hyuck Im
    Eun Yoon Cho
    Yong Sang Hong
    Hyo Rak Lee
    Hyo Song Kim
    Mi-Jin Kim
    Kwhanmien Kim
    Won Ki Kang
    Keunchil Park
    Young Mog Shim
    Cancer Chemotherapy and Pharmacology, 2008, 62 : 77 - 84
  • [3] First-line paclitaxel and cisplatin in patients with advanced squamous-cell carcinoma of the esophagus
    Zhang, X.
    Shen, L.
    Li, J.
    Li, Y.
    Li, J.
    Jin, M. L.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [4] Phase II study of irinotecan as first-line chemotherapy for patients with advanced colorectal carcinoma
    Firvida, JL
    Irigoyen, A
    Vázquez-Estévez, S
    Diz, P
    Constenla, M
    Casal-Rubio, J
    Valladares-Ayerbes, M
    Castellanos, J
    Rodríguez, R
    Balcells, M
    CANCER, 2001, 91 (04) : 704 - 711
  • [5] Phase II trial of first-line chemotherapy with gemcitabine, etoposide, and cisplatin for patients with advanced urothelial carcinoma
    Urakami, Shinji
    Fujii, Yasuhisa
    Yamamoto, Shinya
    Yuasa, Takeshi
    Kitsukawa, Shinichi
    Sakura, Mizuaki
    Yano, Akihiro
    Saito, Kazutaka
    Masuda, Hitoshi
    Yonese, Junji
    Fukui, Iwao
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2014, 32 (01) : 35.e1 - 35.e7
  • [6] A phase II trial of paclitaxel and cisplatin in patients with advanced squamous-cell carcinoma of the esophagus
    Zhang, Xiaodong
    Shen, Lin
    Li, Jie
    Li, Yan
    Li, Jian
    Jin, Maolin
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2008, 31 (01): : 29 - 33
  • [7] Phase II study of nimotuzumab combination with paclitaxel and cisplatin as the first-line treatment in patients with local advanced or metastatic esophageal squamous cell cancer (ESCC): An interim analysis
    Zhang, Xiaodong
    Lu, Ming
    Gong, Jifang
    Gao, Jing
    Wang, Xicheng
    Zhang, Xiaotian
    Li, Jie
    Li, Yan
    Li, Jian
    Zhou, Jun
    Lu, Zhihao
    Shen, Lin
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [8] Phase II clinical trial using camrelizumab combined with apatinib and chemotherapy as the first-line treatment of advanced esophageal squamous cell carcinoma
    Zhang, Bo
    Qi, Ling
    Wang, Xi
    Xu, Jianping
    Liu, Yun
    Mu, Lan
    Wang, Xingyuan
    Bai, Lidan
    Huang, Jing
    CANCER COMMUNICATIONS, 2020, 40 (12) : 711 - 720
  • [9] Prospective Phase II Trial of Gemcitabine in Combination with Irinotecan as First-Line Chemotherapy in Patients with Advanced Biliary Tract Cancer
    Chung, Moon Jae
    Kim, Yoon Jae
    Park, Jeong Youp
    Bang, Seungmin
    Song, Si Young
    Chung, Jae Bock
    Park, Seung Woo
    CHEMOTHERAPY, 2011, 57 (03) : 236 - 243
  • [10] Phase II study of capecitabine and cisplatin as first-line chemotherapy in patients with advanced esophageal cancer
    Hong, Yong S.
    Lee, Hyo R.
    Hwang, In G.
    Lee, Sang C.
    Lee, Jeeyun
    Park, Joon O.
    Park, Young S.
    Lim, Ho Y.
    Im, Young-Hyuck
    Kang, Won K.
    ANNALS OF ONCOLOGY, 2006, 17 : 314 - 314
12345